
0:00
13:29
This week's episode focuses on metastatic non-small cell lung cancer - the quickly growing and changing systemic therapy landscape, including traditional chemotherapy, immunotherapy, and targeted agents. Since our last recording the number of FDA-approved targeted drugs has significantly expanded.
D'autres épisodes de "Two Onc Docs"



Ne ratez aucun épisode de “Two Onc Docs” et abonnez-vous gratuitement à ce podcast dans l'application GetPodcast.








